Continuous Glucose Monitoring versus Standard of Care in Adolescents With Type 2 Diabetes: A Pilot Randomized Cross-Over Trial.

Plain Language Summary

Youth with type 2 diabetes (T2D) develop early treatment failure and are at risk for diabetes-related comorbidities. Continuous glucose monitoring (CGM) can decrease the burden of diabetes care, improve consistent medication administration, and achieve in-target HbA1c in this patient population. The aim of this study was to compare CGM with standard care in adolescents diagnosed with T2D. This study was a pilot randomised cross-over trial. Participants were adolescents with T2D who received either CGM or standard care. Results showed that both CGM and standard care led to reductions in HbA1c levels. However, CGM use was associated with improved user satisfaction. The impact on body composition, blood pressure, and lipid levels remains unclear. Authors concluded that real-time CGM is feasible and acceptable for adolescents with T2D, potentially improving their quality of life. Larger trials are needed to assess effects on glycaemic control and lifestyle changes.